Worth Venture Partners’s Amgen AMGN Stock Holding History

Worth Venture Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,548	Closed	-$2.25M	–	97
2019 Q1	$2.38M	Buy	+12,548	New	+$2.4M	1.33%	14

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Worth Venture Partners's AMGN Position: Q2 2019 in Review

Worth Venture Partners sold out of Amgen (AMGN) in Q2 2019, closing a stake of 12,548 shares — an estimated $2.25M sold.

Worth Venture Partners first reported a position in AMGN in Q1 2019 and held it in 1 quarter. The position peaked at $2.38M in Q1 2019. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

Worth Venture Partners reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
Worth Venture Partners sold 12,548 Amgen shares in Q2 2019, an estimated $2.25M.
Worth Venture Partners first reported a position in Amgen in Q1 2019 and held it in 1 quarter.
Worth Venture Partners's Amgen position peaked at $2.38M in Q1 2019.
1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Worth Venture Partners's 13F filing for Q2 2019, filed 14 Aug 2019.